The approval of the vaccine, called mFLUSIVA, which is manufactured by Moderna, follows a series of blows to mRNA research ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...
The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the ...
The agency's former top vaccine regulator declined to review the Moderna shot, and it's now likely to face pushback from ...
Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot. Reading time 3 minutes The federal government’s crusade against ...
Aug 5 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval of a messenger ...
FLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be ...